Connect with us

Technology

Long-lost Sphinxes of Egyptian King Amenhotep III Unearthed at Luxor

Avatar

Published

on

Enlarge (credit: Egyptian Ministry of Tourism and Antiquities)

Archaeologists in Egypt recently rediscovered two sphinxes that guarded the mortuary temple of Pharaoh Amenhotep III, the grandfather of Tutankhamun. Despite 3,400 years of weathering, the sphinxes still bear the carved limestone face of the pharaoh, who is adorned with a royal headdress and beard. The pair of 8-meter-long sphinxes flank the entrance to a processional avenue, which celebrants would have followed from the main part of the temple to a columned courtyard.

The Temple of Millions of Years lasted less than a century

Amenhotep III ordered the temple, which he called the Temple of Millions of Years, to be built late in his reign. The temple served as a monument to the pharaoh’s rule—think of it as an especially grand, monarchist version of a US presidential library—but also as a temple where priests could hold rituals and make offerings to the dead pharaoh, who was worshipped as a god.

The sprawling 35-hectare complex stood across the Nile River from the ancient city of Thebes, where Amenhotep III ruled in life. It’s also not far from the Valley of the Kings and Amenhotep III’s royal tomb. Ancient records describe the earthquake that destroyed most of the temple in about 1200 BCE, leaving only two 18-meter-tall, 720-ton statues of Amenhotep III standing.

Read 8 remaining paragraphs | Comments

Original Article: arstechnica.com

Technology

Truist Sees 350% Upside on This Cancer-Focused Biopharma Stock – Read Why

Avatar

Published

on

Truist has initiated coverage on Verastem Oncology Inc (NASDAQ: VSTM) with a Buy rating and $6.00 price target, equivalent to approximately 350% upside.
Analyst Srikripa Devarakonda notes that trading at about 2-times cash, the stock is “undervalued” given its programs in two cancers.
Devarakonda adds that the Verastem base case is supported by a $470 million unadjusted U.S. opportunity in the ovarian cancer program, “early but strong” clinical data, and positive expert feedback.
Related: 

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Technology

“Peek Performance”: Apple’s Next Hardware Event Happens on March 8

Avatar

Published

on

Enlarge (credit: Apple)

Apple will stream its next hardware event to the masses on March 8 at 10 am Pacific (1 pm Eastern), the company announced today. Invitations have already been sent to the press—though the event will be yet another prerecorded, streaming-only presentation with no media in attendance. Apple marketing SVP Greg Joswiak tweeted the now-customary Apple-logo-centric teaser video that doesn’t actually tease anything.

We never know exactly what will be announced at any given Apple event, but Bloomberg’s Mark Gurman reports that the lineup will include a refresh of the budget-friendly iPhone SE and the first iPad Air update in a little over a year.

Rumors have also circulated about updated designs and new Apple Silicon chips for the MacBook Air and the 13-inch MacBook Pro, and the high-end Intel Mac Mini, the 27-inch iMac, and the Mac Pro are all still running Intel chips. The characteristically cryptic “peek performance” tagline does at least hint at new chips for one or more Macs, whether that’s a truly next-gen Apple M2 for thin-and-light laptops or an M1 Pro/Max-focused refresh for the more powerful desktops.

Read 1 remaining paragraphs | Comments

Original Article: arstechnica.com

Continue Reading

Technology

Charles River’s Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook

Avatar

Published

on

Charles River Laboratories International Inc’s (NYSE: CRLQ4 sales increased 14.4% Y/Y to $905.1 million, beating the consensus of $888.27 million.

Acquisitions contributed 5.9% to consolidated fourth-quarter revenue growth. Organic revenue growth was 10.5%, driven by contributions from all three business segments. 
Adjusted EPS reached $2.49 higher than $2.39 posted a year ago and …

Full story available on Benzinga.com

Article: benzinga.com

Continue Reading

Trending

WOC.io